92 related articles for article (PubMed ID: 3474303)
21. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
[TBL] [Abstract][Full Text] [Related]
23. Expression of specific high-affinity binding sites for erythropoietin on rat and mouse megakaryocytes.
Fraser JK; Tan AS; Lin FK; Berridge MV
Exp Hematol; 1989 Jan; 17(1):10-6. PubMed ID: 2535696
[TBL] [Abstract][Full Text] [Related]
24. The functional form of the erythropoietin receptor is a 78-kDa protein: correlation with cell surface expression, endocytosis, and phosphorylation.
Sawyer ST; Hankins WD
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6849-53. PubMed ID: 8341708
[TBL] [Abstract][Full Text] [Related]
25. Erythropoietin increases the radioresistance of a clonal hematopoietic progenitor cell line expressing a transgene for the erythropoietin receptor.
Santucci MA; Pierce JH; Zannini S; Fortuna A; Frezza G; Babini L; Rosenstein MM; Greenberger JS
Stem Cells; 1994 Sep; 12(5):506-13. PubMed ID: 7804124
[TBL] [Abstract][Full Text] [Related]
26. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
[TBL] [Abstract][Full Text] [Related]
27. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
Gewirtz DA; Di X; Walker TD; Sawyer ST
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
[TBL] [Abstract][Full Text] [Related]
28. Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF receptors.
Rusnati M; Urbinati C; Presta M
J Cell Physiol; 1993 Jan; 154(1):152-61. PubMed ID: 8419401
[TBL] [Abstract][Full Text] [Related]
29. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells.
Taniguchi S; Dai CH; Krantz SB
Exp Hematol; 1997 Mar; 25(3):193-8. PubMed ID: 9091293
[TBL] [Abstract][Full Text] [Related]
30. Abnormal erythropoietin (Epo) gene expression in the murine erythroleukemia IW32 cells results from a rearrangement between the G-protein beta2 subunit gene and the Epo gene.
Chrétien S; Duprez V; Maouche L; Gisselbrecht S; Mayeux P; Lacombe C
Oncogene; 1997 Oct; 15(16):1995-9. PubMed ID: 9365246
[TBL] [Abstract][Full Text] [Related]
31. Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction.
Philo JS; Aoki KH; Arakawa T; Narhi LO; Wen J
Biochemistry; 1996 Feb; 35(5):1681-91. PubMed ID: 8634300
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the WSAWSE and cytosolic domains of the erythropoietin receptor affect signal transduction and ligand binding and internalization.
Quelle DE; Quelle FW; Wojchowski DM
Mol Cell Biol; 1992 Oct; 12(10):4553-61. PubMed ID: 1406645
[TBL] [Abstract][Full Text] [Related]
33. Hemin or butyrate increases constitutive erythropoietin formation by mouse erythroleukemia cell lines.
Hermine O; Dong YJ; Beru N; Goldwasser E
Exp Hematol; 1993 Aug; 21(9):1207-11. PubMed ID: 8330646
[TBL] [Abstract][Full Text] [Related]
34. Activation of the erythropoietin gene in the majority of F-MuLV-induced erythroleukemias results in growth factor independence and enhanced tumorigenicity.
Howard JC; Berger L; Bani MR; Hawley RG; Ben-David Y
Oncogene; 1996 Apr; 12(7):1405-15. PubMed ID: 8622856
[TBL] [Abstract][Full Text] [Related]
35. Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists.
Hoyer D; Reynolds EE; Molinoff PB
Mol Pharmacol; 1984 Mar; 25(2):209-18. PubMed ID: 6142414
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the erythropoietin receptor on a Friend murine erythroleukemic cell clone, TSA8.
Kitamura T; Tojo A; Fukamachi H; Akahane K; Saito T; Urabe A; Takaku F
Nihon Ketsueki Gakkai Zasshi; 1988 Jul; 51(4):677-85. PubMed ID: 2849278
[No Abstract] [Full Text] [Related]
37. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
[TBL] [Abstract][Full Text] [Related]
38. Identification and analysis of human erythropoietin receptors on a factor-dependent cell line, TF-1.
Kitamura T; Tojo A; Kuwaki T; Chiba S; Miyazono K; Urabe A; Takaku F
Blood; 1989 Feb; 73(2):375-80. PubMed ID: 2537111
[TBL] [Abstract][Full Text] [Related]
39. Tritrichomonas foetus: iron acquisition from lactoferrin and transferrin.
Tachezy J; Kulda J; Bahníková I; Suchan P; Rázga J; Schrével J
Exp Parasitol; 1996 Jul; 83(2):216-28. PubMed ID: 8682190
[TBL] [Abstract][Full Text] [Related]
40. Binding and receptor-mediated endocytosis of erythropoietin in Friend virus-infected erythroid cells.
Sawyer ST; Krantz SB; Goldwasser E
J Biol Chem; 1987 Apr; 262(12):5554-62. PubMed ID: 3032937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
